Eurordat Soft Capsule 0.5mg (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 capsule (0.5mg) once daily. Because exposure to the capsule contents may cause irritation of the oropharyngeal mucosa, swallow this medicine whole without chewing or splitting it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or older adults. The recommended dose of this medicine in patients with hepatic impairment has not been established because no data are available on administration to these patients.

This medication can be absorbed through the skin, so women who are pregnant or who may become pregnant should not touch or handle this medication. If the capsule leaks and comes into contact with the skin, the affected area should be washed thoroughly with soap and water immediately. This medication is prohibited for use in children under 18 years of age, and its safety and efficacy in this age group has not been confirmed. Patients who are allergic to this medication or its ingredients should not take it. Adult males planning to conceive should consult a doctor before careful use, as this medication may affect reproductive capacity. Caution is needed when administering this medication to patients with urinary obstruction or liver dysfunction, and symptoms should be closely monitored. Since this medication is metabolized in the liver, patients with liver impairment should definitely consult a doctor before taking it. Patients taking strong CYP3A4 enzyme inhibitors should be cautious as the blood concentration of this medication may increase. During treatment with this medication, adverse sexual responses such as erectile dysfunction, decreased libido, and ejaculation disorders may occur, and in some cases, these conditions may persist even after discontinuation. In clinical trials, rare breast-related adverse reactions such as breast tenderness or breast enlargement have been reported. This medication may reduce PSA levels for prostate cancer testing, so caution is required in interpreting PSA levels after use, and regular testing is recommended. During the use of this medication, blood donation should be avoided, and blood donation can only occur at least 6 months after the last dose. There is no specific antidote in case of overdose, so appropriate supportive treatment should be administered based on symptoms. Keep this medication out of reach of children, and store it in its original container to prevent deterioration or misuse. It does not affect driving or operating machinery, but caution should be exercised if adverse reactions occur. In patients with heart failure, the risk of heart failure may increase when this medication is combined with other drugs, so caution is needed. This medication may interact with multiple drugs, so if taking other medications, consult a doctor or pharmacist. Pregnant women should not use this medication, and breastfeeding is also prohibited. Adverse reactions may still occur even with long-term use of this medication, so regular evaluation by healthcare professionals is necessary.

• Erectile dysfunction
• decreased libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best to keep it in a cool place away from direct sunlight and below 30 degrees Celsius. This will help maintain the medication's efficacy for a prolonged period.

Appearance

An opaque, cloudy yellow rectangular soft capsule containing a colorless transparent liquid.

Package unit

30 capsules (10 capsules/ PTP packaging * 3)